COVID-19 News from the Clinical Trials Community
Relevant Blog Posts from CTO:
- Clinical trials happening globally to halt COVID-19
- Coronavirus: Ontario researchers race toward treatment, vaccine for COVID-19
- Opinion: Why do vaccines take so long?
- #TalkClinicalTrials: Andre Valleteau’s COVID-19 Experience
- St. Michael’s researcher at the forefront of the COVID-19 global response
- How Private Research Networks are responding to the COVID-19 Pandemic
- Ontario’s clinical trials community rises to the COVID-19 challenge
- #TalkClinicalTrials: Rare Disease, Hydroxychloroquine & COVID-19\
- Ontario Researchers Collaborate to Study Acai Berry Palm Extract as an Intervention in COVID-19 Patients
Relevant news from the community:
- Two COVID-19 research projects from St. Michael’s receive federal funding
- Canada commits $192 million to COVID-19 SIF stream, signs deal with BlueDot to help track, make decisions on virus
- UHN researchers studying if popular drug protects healthcare workers from COVID-19
- Research team at Sunnybrook has isolated the COVID-19 Virus
- Western University researchers begin work on COVID-19 vaccine
- Lawson researchers mobilizing hospital-based research in the battle against COVID-19
- Ottawa Hospital Researchers join the fight against COVID-19
- Canada begins clinical trial of experimental COVID-19 treatment using plasma from recovered individuals
- Cancer-killing viruses provide inspiration for COVID-19 vaccine at the Ottawa Hospital
- Can intravenous vitamin C help critically ill COVID-19 patients? Sunnybrook’s LOVIT trial aims to find out
- Can an existing HIV medication slow the spread of COVID-19? Team of Toronto researchers launches clinical trial to find out
- London researchers join global initiative to study loss of smell in COVID-19 patients
- Canadian hospitals trialing new treatment options for COVID-19 patients
- HHS, McMaster, and PHRI launch national post-operative virtual care study
- Ottawa Hospital researchers study experimental stem cell therapy for COVID-19
- Unity Health research is changing lives for COVID-19 patients
- Canadian government signed new deals with Pfizer and Moderna for coronavirus vaccine candidates
- Remdesivir approved by Health Canada to help treat Canadians with severe symptoms of COVID-19
- Lawson Research Institute is conducting a study using surfactant on COVID-19 patients requiring ventilation
- The Ottawa Hospital launched an innovative clinical trial testing a novel immune boosting strategy in order to protect cancer patients from COVID-19
